Transplant Complications Working Party (TCWP)
Study type:
Study number:
Type of Stem Cell Treatment:
Allogeneic
Diseases:
Short title:
TROP
Primary objective:
Key inclusion criteria:
All first allo HSCTs 2000-2018 for patients aged 40+ years
Country:
Principal investigator:
Johannes Schetelig; Liesbeth de Wreede‬